Parallax Volatility Advisers, L.P. Pulmonx Corp Call Options Transaction History

Parallax Volatility Advisers, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$7.49 - $12.54 $374,500 - $627,000	50,000 New	50,000 $559,000
Q3 2021 Nov 15, 2021	SELL	$35.98 - $44.48 $2.35 Million - $2.91 Million	-65,400 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $2.46 Million - $3.14 Million	65,400 New	65,400 $2.89 Million

124

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $230M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.